Organ-specific management and supportive care in chronic graft-versus-host disease

British Journal of Haematology

Volumn 158, Issue 1, 2012, Pages 62-78

  Dignan, Fiona L ^a,b   Scarisbrick, Julia J ^c   Cornish, Jacqueline ^d   Clark, Andrew ^e   Amrolia, Persis ^f   Jackson, Graham ^g   Mahendra, Prem ^c   Taylor, Peter C ^h   Shah, Pallav ⁱ   Lightman, Sue ^j   Fortune, Farida ^k   Kibbler, Christopher ^l   Andreyev, Jervoise ^a   Albanese, Assunta ^m   Hadzic, Nedim ⁿ   Potter, Michael N ^a   Shaw, Bronwen E ^a,o  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^e BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^f GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^g Hospital   (United Kingdom)

^h ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

ⁱ ROYAL BROMPTON HOSPITAL   (United Kingdom)

^j MOORFIELDS EYE HOSPITAL   (United Kingdom)

^k BARTS HEALTH NHS TRUST   (United Kingdom)

^l ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^m ST GEORGE S HOSPITAL   (United Kingdom)

ⁿ KING S COLLEGE HOSPITAL   (United Kingdom)

^o Anthony Nolan   (United Kingdom)

more..

Author keywords

Chronic; Graft versus host disease; Supportive care; Transplant

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ARTIFICIAL TEAR; AZITHROMYCIN; CALCINEURIN INHIBITOR; CORTICOSTEROID; EMOLLIENT AGENT; HAEMOPHILUS INFLUENZAE VACCINE; IMATINIB; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; ITRACONAZOLE; LIVE VACCINE; LUBRICATING AGENT; METHYLPREDNISOLONE; MOUTHWASH; PIMECROLIMUS; PNEUMOCOCCUS VACCINE; POSACONAZOLE; PREDNISOLONE; PYRROLE DERIVATIVE; SPIRONOLACTONE; STEROID; TACROLIMUS; UNINDEXED DRUG; URSODEOXYCHOLIC ACID; VITAMIN K GROUP; VORICONAZOLE;

ANOREXIA; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MONITORING; BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; CANCER RISK; CHRONIC GRAFT VERSUS HOST DISEASE; COLONOSCOPY; CYTOMEGALOVIRUS INFECTION; DERMATOLOGY; DERMATOPATHIC CONTRACTURE; DIARRHEA; DIETITIAN; DRUG MEGADOSE; DRUG PULSE THERAPY; DYSPHAGIA; ENDOSCOPY; ERYTHEMA; EYE SURGERY; FORCED VITAL CAPACITY; GASTROENTEROLOGY; GASTROINTESTINAL SURGERY; GENITAL ORGAN TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONE SUBSTITUTION; HUMAN; LEG ULCER; LICHENOID; LIVER FAILURE; LIVER TRANSPLANTATION; LONG TERM CARE; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG TRANSPLANTATION; MASSAGE; MOUTH HYGIENE; MYCOSIS; NAIL DYSTROPHY; NAUSEA; NUTRITIONAL ASSESSMENT; OPHTHALMOLOGY; ORAL SURGERY; ORGAN TRANSPLANTATION; PATIENT REFERRAL; PHOTOTHERAPY; PHYSIOTHERAPY; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; PUVA; QUALITY OF LIFE; SCLERODERMOID DISEASE; SEXUAL HEALTH; SKIN CANCER; SKIN CARE; SKIN DISEASE; SKIN EDEMA; SKIN EXAMINATION; SKIN INFECTION; SKIN PIGMENTATION; SKIN TRANSPLANTATION; STEATORRHEA; STREPTOCOCCUS PNEUMONIA; TREATMENT INDICATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; UVEITIS; VACCINATION; VIRUS INFECTION; VOMITING; XEROSIS;

CHRONIC DISEASE; DISEASE MANAGEMENT; GRAFT VS HOST DISEASE; HUMANS; PALLIATIVE CARE;

EID: 84862254875     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09131.x     Document Type: Article

References (121)

1. Albert, M.H., Becker, B., Schuster, F.R., Klein, B., Binder, V., Adam, K., Nienhoff, C., Führer, M. & Borkhardt, A. (2007) Oral graft vs. host disease in children-treatment with topical tacrolimus ointment. Pediatric Transplantation, 11, 306-311.
2. Atkinson, K., Weller, P., Ryman, W. & Biggs, J. (1986) PUVA therapy for drug-resistant graft-versus-host disease. Bone Marrow Transplantation, 1, 227-236.
3. Au, W.Y., Yeung, C.K., Cheung, M.C. & Trendell-Smith, N.J. (2008) Penile lichen sclerosus after allogeneic stem cell transplantation. British Journal of Dermatology, 159, 470-472.
4. Ayala, E., Greene, J., Sandin, R., Perkins, J., Field, T., Tate, C., Fields, K.K. & Goldstein, S. (2006) Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 37, 851-856.
5. Bachrach, L.K. & Ward, L.M. (2009) Clinical review 1: Bisphosphonate use in childhood osteoporosis. Journal of Clinical Endocrinology and Metabolism, 94, 400-409.
6. Bacigalupo, A., Bregante, S., Tedone, E., Isaza, A., Van Lint, M.T., Trespi, G., Occhini, D., Gualandi, F., Lamparelli, T. & Marmont, A.M. (1996) Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation. Transplantation, 62, 376-380.
7. Bashoura, L., Gupta, S., Jain, A., Couriel, D.R., Komanduri, K.V., Eapen, G.A., Safdar, A., Broglio, K.R., Adachi, R. & Dickey, B.F. (2008) Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Bone Marrow Transplantation, 41, 63-67.
8. Bass, E.B., Powe, N.R., Goodman, S.N., Graziano, S.L., Griffiths, R.I., Kickler, T.S. & Wingard, J.R. (1993) Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis. Bone Marrow Transplantation, 12, 273-282.
9. Bergmann, O.J., Ellermann-Eriksen, S., Mogensen, S.C. & Ellegaard, J. (1995) Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: randomised, double blind, placebo controlled trial. British Medical Journal, 310, 1169-1172.
10. Boeckh, M., Gooley, T.A., Myerson, D., Cunningham, T., Schoch, G. & Bowden, R.A. (1996) Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood, 88, 4063-4071.
11. Boeckh, M., Kim, H.W., Flowers, M.E., Meyers, J.D. & Bowden, R.A. (2006) Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation - a randomized double-blind placebo-controlled study. Blood, 107, 1800-1805.
12. Busca, A., de Fabritiis, P., Ghisetti, V., Allice, T., Mirabile, M., Gentile, G., Locatelli, F. & Falda, M. (2007) Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation. Transplant Infectious Disease, 9, 102-107.
13. Calzavara, P.P., Porta, F., Izzi, T., Venturini, M., Capezzera, R., Zane, C. & Notarangelo, L.D. (2003) Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease. Haematologica, 88, 1169-1175.
14. Cesaro, S., Zhou, X., Manzardo, C., Buonfrate, D., Cusinato, R., Tridello, G., Mengoli, C., Palù, G. & Messina, C. (2005) Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation. Journal of Clinical Virology, 34, 129-132.
15. Chavan, R. & el-Azhary, R. (2011) Cutaneous graft-versus-host disease: rationales and treatment options. Dermatologic Therapy, 24, 219-228.
16. Chen, C.S., Boeckh, M., Seidel, K., Clark, J.G., Kansu, E., Madtes, D.K., Wagner, J.L., Witherspoon, R.P., Anasetti, C., Appelbaum, F.R., Bensinger, W.I., Deeg, H.J., Martin, P.J., Sanders, J.E., Storb, R., Storek, J., Wade, J., Siadak, M., Flowers, M.E. & Sullivan, K.M. (2003) Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation. Bone Marrow Transplantation, 32, 515-522.
17. Chiang, C.C., Lin, J.M., Chen, W.L. & Tsai, Y.Y. (2007) Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Cornea, 26, 861-863.
18. Chien, J.W., Martin, P.J., Gooley, T.A., Flowers, M.E., Heckbert, S.R., Nichols, W.G. & Clark, J.G. (2003) Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. American Journal of Respiratory and Critical Care Medicine, 168, 208-214.
19. Chien, J.W., Duncan, S., Williams, K.M. & Pavletic, S.Z. (2010) Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 16(1 Suppl): S106-S114.
20. Choi, C.J. & Nghiem, P. (2001) Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. Archives of Dermatology, 137, 1202-1206.
21. Couriel, D., Carpenter, P.A., Cutler, C., Bolaños-Meade, J., Treister, N.S., Gea-Banacloche, J., Shaughnessy, P., Hymes, S., Kim, S., Wayne, A.S., Chien, J.W., Neumann, J., Mitchell, S., Syrjala, K., Moravec, C.K., Abramovitz, L., Liebermann, J., Berger, A., Gerber, L., Schubert, M., Filipovich, A.H., Weisdorf, D., Schubert, M.M., Shulman, H., Schultz, K., Mittelman, B., Pavletic, S., Vogelsang, G.B., Martin, P.J., Lee, S.J. & Flowers, M.E. (2006) Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group report. Biology of Blood and Marrow Transplantation, 12, 375-396.
22. Deeg, H.J., Seidel, K., Bruemmer, B., Pepe, M.S. & Appelbaum, F.R. (1995) Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplantation, 15, 461-468.
23. Dignan, F.L., Clark, A., Amrolia, P., Cornish, J., Jackson, G., Mahendra, P., Scarisbrick, J.J., Taylor, P.C., Hadzic, N., Shaw, B.E., Potter, M.N. & on behalf of the Haemato-oncology Task Force of the British Committee for Standards in Haematology and the British Society for Blood and Marrow Transplantation (2012a) Diagnosis and management of acute graft-versus-host disease. British Journal of Haematology, 158, 30-45.
24. Dignan, F.L., Amrolia, P., Clark, A., Cornish, J., Jackson, G., Mahendra, P., Scarisbrick, J.J., Taylor, P.C., Shaw, B.E., Potter, M.N. & on behalf of the Haemato-oncology Task Force of the British Committee for Standards in Haematology and the British Society for Blood and Marrow Transplantation (2012b) Diagnosis and management of chronic graft-versus-host disease. British Journal of Haematology, 158, 46-61.
25. Dudek, A.Z., Mahaseth, H., De For, T.E. & Weisdorf, D.J. (2003) Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biology of Blood and Marrow Transplantation, 9, 657-66.
26. Eckardt, A., Starke, O., Stadler, M., Reuter, C. & Hertenstein, B. (2004) Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus. Oral Oncology, 40, 811-814.
27. Einsele, H., Reusser, P., Bornhauser, M., Kalhs, P., Ehninger, G., Hebart Chalandon, H.Y., Kröger, N., Hertenstein, B. & Rohde, F. (2006) Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation. Blood, 107, 3002-3008.
28. El Cheikh, J., Castagna, L., Wang, L., Esterni, B., Faucher, C., Furst, S., Duran, S., Berger, P., Ranque, S., Mohty, M. & Blaise, D. (2010) Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center study. Hematology/Oncology Stem Cell Therapy, 3, 167-173.
29. Elad, S., Or, R., Resnick, I. & Shapira, M.Y. (2003a) Topical tacrolimus: a novel treatment alternative for cutaneous chronic graft-versus-host disease. Transplant International, 16, 665-670.
30. Elad, S., Or, R., Garfunkel, A.A. & Shapira, M.Y. (2003b) Budesonide: a novel treatment for oral chronic graft versus host disease. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, Endodontology, 95, 308-311.
31. Engelhard, D., Cordonnier, C., Shaw, P.J., Parkalli, T., Guenther, C., Martino, R., Dekker, A.W., Prentice, H.G., Gustavsson, A., Nurnberger, W., Ljungman, P. & Infectious Disease Working Party of the European Bone Marrow Transplantation (IDWP-EBMT). (2002) Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. British Journal of Haematology, 117, 444-450.
32. Engelhard, D., Akova, M., Boeckh, M.J., Freifeld, A., Sepkowitz, K., Viscoli, C., Wade, J., Raad, I. & Center for International Blood and Marrow Transplant Research; National Marrow Donor Program; European Blood and Marrow Transplant Group; American Society of Blood and Marrow Transplantation; Canadian Blood and Marrow Transplant Group; Infectious Disease Society of America; Society for Healthcare Epidemiology of America; Association of Medical Microbiology and Infectious Diseases Canada; Centers for Disease Control and Prevention (2009) Bacterial infection prevention after hematopoietic cell transplantation. Bone Marrow Transplantation, 44, 467-470.
33. Enk, C.D., Elad, S., Vexler, A., Kapelushnik, J., Gorodetsky, R. & Kirschbaum, M. (1998) Chronic graft-versus-host disease treated with UVB phototherapy. Bone Marrow Transplantation, 22, 1179-1183.
34. Eppinger, T., Ehninger, G., Steinert, M., Niethammer, D. & Dopfer, R. (1990) 8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease. Transplantation, 50, 807-811.
35. Epstein, J.B. & Reece, D.E. (1994) Topical ciclosporin A for treatment of oral chronic graft-versus-host disease. Bone Marrow Transplantation, 13, 81-86.
36. Ervin, A.M., Wojciechowski, R. & Schein, O. (2010) Punctal occlusion for dry eye syndrome. Cochrane Database of Systematic Reviews, 8(9), CD006775.
37. Filipovich, A.H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J.R., Lee, S.J., Martin, P., Chien, J., Przepiorka, D., Couriel, D., Cowen, E.W., Dinndorf, P., Farrell, A., Hartzman, R., Henslee-Downey, J., Jacobsohn, D., McDonald, G., Mittleman, B., Rizzo, J.D., Robinson, M., Schubert, M., Schultz, K., Shulman, H., Turner, M., Vogelsang, G. & Flowers, M.E. (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biology of Blood and Marrow Transplantation, 11, 945-956.
38. Flowers, M.E., Parker, P.M., Johnston, L.J., Matos, A.V., Storer, B., Bensinger, W.I., Storb, R., Appelbaum, F.R., Forman, S.J., Blume, K.G. & Martin, P.J. (2002) Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood, 100, 415-419.
39. França, C.M., Domingues-Martins, M., Volpe, A., Pallotta Filho, R.S. & Soares de Araújo, N. (2001) Severe oral manifestations of chronic graft-vs.-host disease. Journal of the American Dental Association, 132, 1124-1127.
40. Fricain, J.C., Sibaud, V., Swetyenga, N., Tabrizi, R., Campana, F. & Taïeb, A. (2007) Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease. British Journal of Dermatology, 156, 588-590.
41. Fuji, S., Kim, S.W., Yoshimura, K., Akiyama, H., Okamoto, S., Sao, H., Takita, J., Kobayashi, N., Mori, S. & Japan Marrow Donor Program. (2009) Possible association between obesity and posttransplantation complications including infectious diseases and acute graft-versus-host disease. Biology of Blood and Marrow Transplantation, 15, 73-82.
42. Gergis, U., Markey, K., Greene, J., Kharfan-Dabaja, M., Field, T., Wetzstein, G., Schell, M.J., Huang, Y., Anasetti, C. & Perkins, J. (2010) Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD. Bone Marrow Transplantation, 45, 662-667.
43. Ghoreschi, K., Thomas, P., Penovici, M., Ullmann, J., Sander, C.A., Ledderose, G., Plewig, G., Kolb, H.J. & Röcken, M. (2008) PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease. European Journal of Dermatology, 18, 667-670.
44. Gluckman, E., Lotsberg, J., Devergie, A., Zhao, X.M., Melo, R., Gomez-Morales, M., Nebout, T., Mazeron, M.C. & Perol, Y. (1983) Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir. Lancet, 2, 706-708.
45. Goodrich, J.M., Bowden, R.A., Fisher, L., Keller, C., Schoch, G. & Meyers, J.D. (1993) Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Annals of Internal Medicine, 118, 173-178.
46. Grigg, A.P., Brown, M., Roberts, A.W., Szer, J. & Slavin, M.A. (2004) A pilot study of targeted itraconazole prophylaxis in patients with graft-versus-host disease at high risk of invasive mould infections following allogeneic stem cell transplantation. Bone Marrow Transplantation, 34, 447-453.
47. Grundmann-Kollmann, M., Behrens, S., Gruss, C., Gottlober, P., Peter, R.U. & Kerscher, M. (2000) Chronic sclerodermic graft-versus host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. Journal of American Academy of Dermatology, 42, 134-136.
48. Hann, I.M., Prentice, H.G., Blacklock, H.A., Ross, M.G., Brigden, D., Rosling, A.E., Burke, C., Crawford, D.H., Brumfitt, W. & Hoffbrand, A.V. (1983) Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. British Medical Journal (Clinical Research Edition), 287, 384-388.
49. Häusermann, P., Walter, R.B., Halter, J., Biedermann, B.C., Tichelli, A., Itin, P. & Gratwohl, A. (2008) Cutaneous graft-versus-host disease: a guide for the dermatologist. Dermatology, 216, 287-304.
50. van der Heiden, P.L., Kalpoe, J.S., Barge, R.M., Willemze, R., Kroes, A.C. & Schippers, E.F. (2006) Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients. Bone Marrow Transplantation, 37, 693-698.
51. Hildebrandt, G.C., Fazekas, T., Lawitschka, A., Bertz, H., Greinix, H., Halter, J., Pavletic, S.Z., Holler, E. & Wolff, D. (2011) Diagnosis and treatment of pulmonary chronic GvHD: report from the consensus conference on clinical practice in chronic GvHD. Bone Marrow Transplantation, 46, 1283-1295.
52. Hilgendorf, I., Freund, M., Jilg, W., Einsele, H., Gea-Banacloche, J., Greinix, H., Halter, J., Lawitschka, A., Wolff, D. & Meisel, R. (2011) Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GvHD. Vaccine, 29, 2825-2833.
53. Jampel, R.M., Farmer, E.R., Vogelsang, G.B., Wingard, J., Santos, G.W. & Morison, W.L. (1991) PUVA therapy for chronic cutaneous graft-vs-host disease. Archives of Dermatology, 127, 1673-1678.
54. Khalid, M., Al Saghir, A., Saleemi, S., Al Dammas, S., Zeitouni, M., Al Mobeireek, A., Chaudhry, N. & Sahovic, E. (2005) Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. European Respiratory Journal, 25, 490-493.
55. Kim, S.K. (2006) Update on ocular graft versus host disease. Current Opinion in Ophthalmology, 17, 344-348.
56. Kojima, T., Higuchi, A., Goto, E., Matsumoto, Y., Dogru, M. & Tsubota, K. (2008) Autologous serum eye drops for the treatment of dry eye diseases. Cornea, 27(Suppl 1), S25-S30.
57. Kopp, M., Schweigkofler, H., Holzner, B., Nachbaur, D., Niederwieser, D., Fleischhacker, W.W., Kemmler, G. & Sperner-Unterweger, B. (2000) EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison. European Journal of Haematology, 65, 97-103.
58. Lam, D.C., Lam, B., Wong, M.K., Lu, C., Au, W.Y., Tse, E.W., Leung, A.Y., Kwong, Y.L., Liang, R.H., Lam, W.K., Ip, M.S. & Lie, A.K. (2011) Effects of Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT-a randomized double-blinded placebo-controlled study. Bone Marrow Transplantation, 46, 1551-1556.
59. Lee, S.J., Klein, J.P., Barrett, A.J., Ringden, O., Antin, J.H., Cahn, J.Y., Carabasi, M.H., Gale, R.P., Giralt, S., Hale, G.A., Ilhan, O., McCarthy, P.L., Socie, G., Verdonck, L.F., Weisdorf, D.J. & Horowitz, M.M. (2002a) Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood, 100, 406-414.
60. Lee, S., Cook, E.F., Soiffer, R. & Antin, J.H. (2002b) Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 8, 444-452.
61. Leiter, U., Kaskel, P., Krahn, G., Gottlöber, P., Bunjes, D., Peter, R.U. & Kerscher, M. (2002) Psoralen plus ultraviolet-A bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease. Photodermatology, Photoimmunology, Photomedicine, 18, 183-190.
62. Lengerke, C., Ljubicic, T., Meisner, C., Loeffler, J., Sinzger, C., Einsele, H. & Hebart, H. (2006) Evaluation ofthe COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation. Bone Marrow Transplantation, 38, 53-60.
63. Ljungman, P., Wilczek, H., Gahrton, G., Gustavsson, A., Lundgren, G., Lonnqvist, B., Ringdén, O. & Wahren, B. (1986) Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro. Bone Marrow Transplantation, 1, 185-192.
64. Ljungman, P., Deliliers, G.L., Platzbecker, U., Matthes-Martin, S., Bacigalupo, A., Einsele, H., Ullmann, J., Musso, M., Trenschel, R., Ribaud, P., Bornhäuser, M., Cesaro, S., Crooks, B., Dekker, A., Gratecos, N., Klingebiel, T., Tagliaferri, E., Ullmann, A.J., Wacker, P. & Cordonnier, C. (2001) Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood, 97, 388-392.
65. Ljungman, P., Camara, De.La.R., Milpied, N., Volin, L., Russell, C.A., Webster, A. & Valacyclovir International Bone Marrow Transplant Study Group. (2002) A randomised study of valaciclovir as prophylaxis against CMV reactivation in allogeneic bone marrow transplant recipients. Blood, 73, 930-936.
66. Ljungman, P., Engelhard, D., de la Cámara, R., Einsele, H., Locasciulli, A., Martino, R., Ribaud, P., Ward, K. & Cordonnier, C. & Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. (2005) Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplantation, 35, 737-746.
67. Ljungman, P., Cordonnier, C., Einsele, H., Englund, J., Machado, C.M., Storek, J., Small, T. & Center for International Blood and Marrow Transplant Research; National Marrow Donor Program; European Blood and Marrow Transplant Group; American Society of Blood and Marrow Transplantation; Canadian Blood and Marrow Transplant Group; Infectious Disease Society of America; Society for Healthcare Epidemiology of America; Association of Medical Microbiology and Infectious Diseases Canada; Centers for Disease Control and Prevention (2009) Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplantation, 44, 521-526.
68. Lucid, C.E., Savani, B.N., Engelhardt, B.G., Shah, P., Clifton, C., Greenhut, S.L., Vaughan, L.A., Kassim, A., Schuening, F. & Jagasia, M. (2011) Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Bone Marrow Transplantation, 46, 426-429.
69. Marks, C., Stadler, M., Häusermann, P., Wolff, D., Buchholz, S., Stary, G., Lee, S., Lawitschka, A. & Bertz, H. (2011a) German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GvHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GvHD. British Journal of Dermatology, 165, 18-29.
70. Marks, D.I., Pagliuca, A., Kibbler, C.C., Glasmacher, A., Heussel, C.P., Kantecki, M., Miller, P.J., Ribaud, P., Schlamm, H.T., Solano, C., Cook, G. & for the IMPROVIT Study Group. (2011b) Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation. British Journal of Haematology, 155, 318-327.
71. Martino, R., Maertens, J., Bretagne, S., Rovira, M., Deconinck, E., Ullmann, A.J., Held, T. & Cordonnier, C. (2000a) Toxoplasmosis after hematopoietic stem cell transplantation. Clinical Infectious Diseases, 31, 1188-1195.
72. Martino, R., Bretagne, S., Rovira, M., Ullmann, A.J., Maertens, J., Held, T., Deconinck, E. & Cordonnier, C. (2000b) Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 25, 1111-1114.
73. Mattes, F.M., Hainsworth, E.G., Geretti, A.M., Nebbia, G., Prentice, G., Potter, M., Burroughs, A.K., Sweny, P., Hassan-Walker, A.F., Okwuadi, S., Sabin, C., Amooty, G., Brown, V.S., Grace, S.C., Emery, V.C. & Griffiths, P.D. (2004) A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at halfdose) for preemptive therapy of cytomegalovirus infection in transplant recipients. Journal of Infectious Diseases, 189, 1355-1361.
74. Mawardi, H., Stevenson, K., Gokani, B., Soiffer, R. & Treister, N. (2010) Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GvHD. Bone Marrow Transplantation, 45, 1062-1067.
75. McQuellon, R.P., Russell, G.B., Cella, D.F., Craven, B.L., Brady, M., Bonomi, A. & Hurd, D.D. (1997) Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplantation, 19, 357-368.
76. Meier, J.K., Wolff, D., Pavletic, S., Greinix, H., Gosau, M., Bertz, H., Lee, S.J., Lawitschka, A. & Elad, S. (2011) Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGvHD. Clinical Oral Investigations, 15, 127-139.
77. Mele, A., Paterson, P.J., Prentice, H.G., Leoni, P. & Kibbler, C.C. (2002) Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplantation, 29, 691-698.
78. Mohty, M., Kuentz, M., Michallet, M., Bourhis, J.H., Milpied, N., Sutton, L., Jouet, J.P., Attal, M., Bordigoni, P., Cahn, J.Y., Boiron, J.M., Blaise, D. & Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) (2002) Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood, 100, 3128-3134.
79. Murray, S.M. & Pindoria, S. (2009) Nutrition support for bone marrow transplant patients. Cochrane Database of Systematic Reviews, 21(1), CD002920.
80. Nagler, R.M. & Nagler, A. (1999) Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study. Bone Marrow Transplantation, 23, 1007-1011.
81. Norman, B.C., Jacobsohn, D.A., Williams, K.M., Au, B.K., Au, M.A., Lee, S.J., Moravec, C.K. & Chien, J.W. (2011) Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients. Bone Marrow Transplantation, 46, 1369-1373.
82. Olivieri, A., Locatelli, F., Zecca, M., Sanna, A., Cimminiello, M., Raimondi, R., Gini, G., Mordini, N., Balduzzi, A., Leoni, P., Gabrielli, A. & Bacigalupo, A. (2009) Imatinib for refractory chronic graft-versus-host disease with fibrotic features. Blood, 114, 709-718.
83. Omar, H., Hägglund, H., Gustafsson-Jernberg, A., LeBlanc, K., Mattsson, J., Remberger, M., Ringdén, O., Sparrelid, E., Sundin, M., Winiarski, J., Yun, Z. & Ljungman, P. (2009) Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction. Transplant Infectious Disease, 11, 393-399.
84. Or, R., Gesundheit, B., Resnick, I., Bitan, M., Avraham, A., Avgil, M., Sacks, Z. & Shapira, M.Y. (2007) Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot study. Transplantation, 83, 577-581.
85. Perren, T.J., Powles, R.L., Easton, D., Stolle, K. & Selby, P.J. (1988) Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation. American Journal of Medicine, 85, 99-101.
86. Pidala, J., Kurland, B., Chai, X., Majhail, N., Weisdorf, D.J., Pavletic, S., Cutler, C., Jacobsohn, D., Palmer, J., Arai, S., Jagasia, M. & Lee, S.J. (2011) Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GvHD Consortium. Blood, 117, 4651-4657.
87. Platzbecker, U., Bandt, D., Thiede, C., Helwig, A., Freiberg-Richter, J., Schuler, U., Plettig, R., Geissler, G., Rethwilm, A., Ehninger, G. & Bornhäuser, M. (2001) Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation. Transplantation, 71, 880-885.
88. Prentice, H.G., Gluckman, E., Powles, R.L., Ljungman, P., Milpied, N., Fernandez Ranada, J.M., Mandelli, F., Kho, P., Kennedy, L. & Bell, A.R. (1994) Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet, 343, 749-753.
89. Ratjen, F., Rjabko, O. & Kremens, B. (2005) High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Bone Marrow Transplantation, 36, 135-138.
90. Reusser, P., Einsele, H., Lee, J., Volin, L., Rovira, M., Engelhard, D., Finke, J., Cordonnier, C., Link, H. & Ljungman, P. & Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. (2002) Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood, 99, 1159-1164.
91. Rhodes, D.F., Lee, W.M., Wingard, J.R., Pavy, M.D., Santos, G.W., Shaw, B.W., Wood, R.P., Sorrell, M.F. & Markin, R.S. (1990) Orthotopic liver transplantation for graft versus host disease following bone marrow transplantation. Gastroenterology, 99, 536-538.
92. Riley, S.A. & Attwood, S.E. (2004) Guidelines on the use of oesophageal dilatation in clinical practice. Gut, 53(Suppl 1), 1-6.
93. Ruutu, T., Eriksson, B., Remes, K., Juvonen, E., Volin, L., Remberger, M., Parkkali, T., Hägglund, H., Ringdén, O. & Nordic Bone Marrow Transplantation Group. (2002) Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood, 100, 1977-1983.
94. Sánchez, A.R., Sheridan, P.J. & Rogers, R.S. (2004) Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report. Journal of Peridontology, 75, 613-619.
95. Saral, R., Burns, W.H., Laskin, O.L., Santos, G.W. & Lietman, P.S. (1981) Acyclovir prophylaxis of herpes-simplex-virus infections. New England Journal of Medicine, 305, 63-67.
96. Sari, I., Altuntas, F., Kocyigit, I., Sisman, Y., Eser, B., Unal, A., Fen, T., Ferahbas, A., Ozturk, A., Unal, A. & Cetin, M. (2007) The effect of budesonide mouthwash on oral chronic graft versus host disease. American Journal of Hematology, 82, 349-356.
97. Schmook, T., Kraft, J., Benninghoff, B., Nindl, I., Roewert, J., Ulrich, C. & Stockfleth, E. (2005) Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus. Bone Marrow Transplantation, 36, 87-88.
98. Schwarer, A.P., Hughes, J.M., Trotman-Dickenson, B., Krausz, T. & Goldman, J.M. (1992) A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation. Transplantation, 54, 1002-1008.
99. Seguy, D., Berthon, C., Micol, J.B., Darré, S., Dalle, J.H., Neuville, S., Bauters, F., Jouet, J.P. & Yakoub-Agha, I. (2006) Enteral feeding and early outcomes of patients undergoing allogeneic stem cell transplantation following myeloablative conditioning. Transplantation, 82, 835-839.
100. Shepp, D.H., Dandliker, P.S., Flournoy, N. & Meyers, J.D. (1987) Sequential intravenous and twice-daily oral acyclovir for extended prophylaxis of herpes simplex virus infection in marrow transplant patients. Transplantation, 43, 654-658.
101. Shulman, H.M., Kleiner, D., Lee, S.J., Morton, T., Pavletic, S.Z., Farmer, E., Moresi, J.M., Greenson, J., Janin, A., Martin, P.J., McDonald, G., Flowers, M.E., Turner, M., Atkinson, J., Lefkowitch, J., Washington, M.K., Prieto, V.G., Kim, S.K., Argenyi, Z., Diwan, A.H., Rashid, A., Hiatt, K., Couriel, D., Schultz, K., Hymes, S. & Vogelsang, G.B. (2006) Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biology of Blood and Marrow Transplantation, 12, 31-47.
102. Singhal, S., Powles, R., Treleaven, J., Rattenbury, H. & Mehta, J. (1997) Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignancies. Leukaemia Lymphoma, 24, 539-543.
103. Spinelli, S., Chiodi, S., Costantini, S., Van Lint, M.T., Raiola, A.M., Ravera, G.B. & Bacigalupo, A. (2003) Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Haematologica, 88, 1163-1168.
104. Spiryda, L.B., Laufer, M.R., Soiffer, R.J. & Antin, J.A. (2003) Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment. Biology of Blood and Marrow Transplantation, 9, 760-765.
105. Stadler, M., Ahlborn, R., Kamal, H., Diedrich, H., Buchholz, S., Eder, M. & Ganser, A. (2009) Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease. Blood, 114, 3718-3719.
106. Stratton, P., Turner, M.L., Childs, R., Barrett, J., Bishop, M., Wayne, A.S. & Pavletic, S. (2007) Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation. Obstetrics & Gynecology, 110, 1041-1049.
107. Svahn, B.M., Remberger, M., Heijbel, M., Martell, E., Wikström, M., Eriksson, B., Milovsavljevic, R., Mattsson, J. & Ringdén, O. (2008) Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition. Transplantation, 85, 1000-1007.
108. Ullmann, A.J., Lipton, J.H., Vesole, D.H., Chandrasekar, P., Langston, A., Tarantolo, S.R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., Pedicone, L., Patino, H. & Durrant, S. (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. New England Journal of Medicine, 356, 335-347.
109. Vogelsang, G.B., Wolff, D., Altomonte, V., Farmer, E., Morison, W.L., Corio, R. & Horn, T. (1996) Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplantation, 17, 1061-1067.
110. Volin, L., Barkholt, L., Nihtinen, A., Aschan, J., Uotinen, H., Hägglund, H., Juvonen, E., Ringdén, O., Ruutu, T. & Ljungman, P. (2008) An open-label randomised study of oral valganciclovir versus intravenous ganciclovir for pre-emptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Bone Marrow Transplantation, 42(Suppl 1), S47.
111. Wertheim, M. & Rosenbaum, J.T. (2005) Bilateral uveitis manifesting as a complication of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Ocular Immunology and Inflammation, 13, 403-404.
112. Westeneng, A.C., Hettinga, Y., Lokhorst, H., Verdonck, L., van Dorp, S. & Rothova, A. (2010) Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea, 29, 758-763.
113. Wetzig, T., Sticherling, M., Simon, J.C., Hegenbart, U., Niederwieser, D. & Al Ali, H.K. (2005) Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin. Bone Marrow Transplantation, 35, 515-519.
114. White, D.A., Wong, P.W. & Downey, R. (2000) The utility of open lung biopsy in patients with hematologic malignancies. American Journal of Respiratory and Critical Care Medicine, 161, 723-729.
115. Winston, D.J., Ho, W.G., Bartoni, K., Du Mond, C., Ebeling, D.F., Buhles, W.C. & Champlin, R.E. (1993) Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial. Annals of Internal Medicine, 118, 179-184.
116. Winston, D.J., Yeager, A.M., Chandrasekar, P.H., Snydman, D.R., Petersen, F.B. & Territo, M.C. (2003) Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation. Clinical Infectious Diseases, 36, 749-758.
117. Winston, D.J., Baden, L.R., Gabriel, D.A., Emmanouilides, C., Shaw, L.M., Lange, W.R. & Ratanatharathorn, V. (2006) Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease ofthe gastrointestinal tract. Biology of Blood and Marrow Transplantation, 12, 635-640.
118. Wolff, D., Anders, V., Corio, R., Horn, T., Morison, W.L., Farmer, E. & Vogelsang, G.B. (2004) Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease. Photodermatology, Photoimmunology, Photomedicine, 20, 184-190.
119. Zantomio, D., Grigg, A.P., MacGregor, L., Panek-Hudson, Y., Szer, J. & Ayton, R. (2006) Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management. Bone Marrow Transplantation, 38, 567-572.
120. Ziemer, M., Gruhn, B., Thiele, J.J. & Elsner, P. (2004a) Treatment of extensive chronic cutaneous graft-versus-host disease in an infant with topical pimecrolimus. Journal of American Academy of Dermatology, 50, 946-948.
121. Ziemer, M., Thiele, J.J., Gruhn, B. & Elsner, P. (2004b) Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life. Journal of American Academy of Dermatology, 51, 318-319.